5,7-Dihydroxy-4-methylcoumarin

5,7-Dihydroxy-4-methylcoumarin (CAS No.: 2107-76-8) is a coumarin derivative used as a small molecule research tool in life sciences, primarily categorized within redox biology and inflammation related pharmacology, with reported antioxidant and cytoprotective activity profiles in preclinical systems and utility as a synthetic intermediate for research oriented compound development; available evidence indicates that its functional background is consistent with plant associated coumarin chemistry and that, in experimental models, it modulates oxidative stress linked signaling by reducing intracellular reactive oxygen species burden, preserving mitochondrial membrane potential, attenuating mitochondrial dysfunction, suppressing apoptosis associated markers including caspase 3, and influencing stress response pathways such as decreased phosphorylated JNK and an increased phosphorylated FoxO1 to total FoxO1 ratio, while additional in vitro findings describe inhibition of neutrophil oxidative metabolism, elastase activity, and cyclooxygenase pathway signaling together with platelet aggregation related effects, supporting its placement as a multi pathway probe for mechanistic studies of oxidative injury, inflammatory signaling, and cell fate regulation; although quantitative potency metrics are not uniformly established across assay formats for this specific molecule, reported activities for coumarin class modulators are generally examined from nanomolar to micromolar range and frequently interpreted at low micromolar levels in biochemical and cell based screens, and representative applications include use in cellular stress and apoptosis models, cisplatin associated ototoxicity related hair cell injury paradigms, and exploratory in vivo validation settings where concentrations or doses used in experiments typically depend on specific experimental designs and research objectives, making this compound suitable for target hypothesis testing, pathway deconvolution, and early stage drug discovery screening in nonclinical research environments only.